The UK Government has issued an indemnity in relation to claims brought against the manufacturers of new ventilators produced to deal with the COVID-19 pandemic in the UK as part of the Government’s campaign for rapidly manufactured ventilator systems (RMVS). A letter from Michael Gove MP to the Chair of the Public Accounts Committee (3 April) confirms that product liability and intellectual property infringement liabilities will be indemnified by the Government.
There is no specific statement of the amount the Government expects may be needed in relation to these RMVS indemnities, other than an indication that it could be over £3 million. A contingent liability for the Government of over £3 million, for which there is not statutory authority, would normally require a 14 day approval process. The exception is in cases of special urgency. In his letter, Mr Gove acknowledges that he is not using the usual procedure for liabilities over £3 million, but is notifying the Public Accounts Committee directly, in order to prevent further delay and allow the contracts for procurement to be concluded.
Mr Gove states that the need for both indemnities is “driven by the unprecedented speed of the development of these medical device. The indemnities are essential for the emergency provision of ventilators, procured at pace“.
The contents of this publication are for reference purposes only and may not be current as at the date of accessing this publication. They do not constitute legal advice and should not be relied upon as such. Specific legal advice about your specific circumstances should always be sought separately before taking any action based on this publication.
© Herbert Smith Freehills 2021